Buy Gland Pharma; target of Rs 5000: Emkay Global Financial Dayanand Saini | December 2, 2021 | Finacial News | No Comments Emkay Global Financial is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 5000 in its research report dated November 29, 2021. Related Posts Cipla — While COVID scope continues, watch out for FY23 No Comments | May 18, 2021 Buy Bharti Airtel; target of Rs 720: Motilal Oswal No Comments | May 21, 2021 Hold Motherson Sumi; target of Rs 150: ICICI Direct No Comments | Dec 8, 2020 Hold Wipro: target of Rs 740: Sharekhan No Comments | Sep 9, 2021 About The Author Dayanand Saini